È«º¸¼¾ÅÍ
°øÁö»çÇ×
°Ô½ÃÆÇ ¸®½ºÆ®
ÁÖÁÖ¿©·¯ºÐµé²² ¾Ë·Áµå¸³´Ï´Ù.
°ü¸®ÀÚ
2020-12-18
4603
ÁÖÁÖ¿©·¯ºÐµé²² ¾Ë·Áµå¸³´Ï´Ù.
°ü¸®ÀÚ
2020-12-17
5165
ÁÖÁÖ¿©·¯ºÐ²² ¾Ë·Áµå¸³´Ï´Ù.
°ü¸®ÀÚ
2020-10-26
6649
ÁÖÁÖ ¿©·¯ºÐ²² ¾Ë·Áµå¸³´Ï´Ù.
°ü¸®ÀÚ
2020-09-22
7309
IR ÀÚ·á (Corporate Overview)
°ü¸®ÀÚ
2020-08-11
7039
¼¼Æ÷Ä¡·áÁ¦ »ý»ê¿ë Á¦2°øÀå ½Ä¾àó Çã°¡
°ü¸®ÀÚ
2020-06-24
5946
°³¹ßÁßÀÎ Á¦Ç° ÁøÇà°èȹ (±¹¹®º»)
°ü¸®ÀÚ
2020-06-24
5526
°³¹ßÁßÀÎ Á¦Ç° ÁøÇà°èȹ
°ü¸®ÀÚ
2020-06-23
4529
ÁÖÁÖ ¿©·¯ºÐ²² ¾Ë·Á µå¸³´Ï´Ù.
°ü¸®ÀÚ
2020-06-17
5517
ÁÖÁÖ ¿©·¯ºÐ²² ¾Ë·Áµå¸³´Ï´Ù
°ü¸®ÀÚ
2020-06-10
4753
302 ÀÓ»ó½ÃÇè Àç°³
°ü¸®ÀÚ
2020-06-09
6630
ALLO-ASC-SheetÀÇ ¹Ì±¹ FDAÀÇ RMAT ÁöÁ¤ÀÇ ÀǹÌ
°ü¸®ÀÚ
2020-05-25
6934
÷´Ü Àç»ýÀÇÇÐ Ä¡·áÁ¦ (Regenerative Medicine Advanced Therapy)¶õ?
°ü¸®ÀÚ
2020-05-25
3934
Company Policy for Expanded Access to Investigational (Unapproved) Drugs
°ü¸®ÀÚ
2020-05-21
4737
´ç´¢º´¼ºÁ·ºÎ±Ë¾çÄ¡·áÁ¦, ¹Ì FDA·ÎºÎÅÍ Ã·´ÜÀç»ýÀÇÇÐÄ¡·áÁ¦(RMAT)·Î ÁöÁ¤½ÂÀÎ
°ü¸®ÀÚ
2020-05-20
4687
Genetic Engineering & Biotechnolgy News º¸µµ³»¿ë
°ü¸®ÀÚ
2020-05-07
4027
ÁÖÁÖ¿©·¯ºÐ²² ¾Ë·Áµå¸³´Ï´Ù.
°ü¸®ÀÚ
2020-04-06
6206
ºÎ±¤¾àǰ º¸À¯ ÁÖ½Ä ÁöºÐÀ² º¯µ¿ °ü·Ã
°ü¸®ÀÚ
2020-03-27
3749
Á¦ 20±â ÁÖÁÖÃÑȸ °ü·Ã ¾È³»»çÇ×
°ü¸®ÀÚ
2020-03-18
2457
¹Ì±¹ Wagner grade II ÀÓ»ó ½ºÅ¸Æ®
°ü¸®ÀÚ
2020-03-16
3700
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
Á¦¸ñ
³»¿ë
±Û¾´ÀÌ
´Ý±â
.
¾ÈÆ®·ÎÁ¨(º»»ç ¹× ÀǾàǰ Á¦Á¶¼Ò) : (08589) ¼¿ïƯº°½Ã ±Ýõ±¸ °¡»êµ¿ 345-30
¾ÈÆ®·ÎÁ¨(Áß¾Ó¿¬±¸¼Ò) : (07805) ¼¿ïƯº°½Ã °¼±¸ ¹ß»ê1µ¿ ¸¶°îÁß¾Ó2·Î 65 / ÀüȹøÈ£: 02-2104-0391~0392
COPYRIGHT (C) 2012 ANTEROGEN.CO.,LTD. ALL RIGHTS RESERVED.